Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/15/2026

Limb Girdle Muscular Dystrophy (LGMD) Diagnosis and Management

Classification and Genetics

  • The American Heart Association notes that Limb Girdle Muscular Dystrophy (LGMD) is a genetically heterogeneous group of inherited muscle disorders characterized by progressive weakness and wasting of the proximal muscles in the hip and shoulder girdles, with significant variability in age of onset, severity, and systemic complications depending on the specific genetic subtype 1, 2, 3
  • The prevalence of LGMD is estimated at 1 in 14,500 to 1 in 123,000 individuals, according to the American Heart Association 1

Clinical Presentation

  • The American Academy of Neurology states that the hallmark feature of LGMD is progressive weakness primarily affecting the pelvic and shoulder girdle musculature 1, 3
  • The American College of Cardiology notes that proximal muscle weakness is greater than distal in LGMD patients 1, 3
  • Scapular winging, progressive contractures, and scoliosis are common clinical features in some subtypes, as reported by the American Academy of Orthopaedic Surgeons 1, 3
  • Calf pseudohypertrophy is observed in certain subtypes, according to the American Academy of Neurology 1, 3

Systemic Complications

Cardiac Involvement

  • The American College of Cardiology recommends that cardiac complications, including dilated and hypertrophic cardiomyopathies, atrial and ventricular arrhythmias, and various degrees of heart block, be monitored in LGMD patients 1, 2
  • Cardiac involvement is particularly common in lamin A/C-related LGMD (LGMD1B) and sarcoglycan-deficient LGMD (LGMD2C-F), as noted by the American Heart Association 1, 3

Respiratory Involvement

  • The American Thoracic Society states that respiratory muscle weakness can lead to progressive respiratory insufficiency, sleep-disordered breathing, and increased risk of respiratory infections in LGMD patients 4, 5

Diagnosis

  • The American College of Medical Genetics recommends that serum creatine kinase (CK) levels be checked, as they are typically elevated in LGMD patients, though levels vary by subtype 6, 5
  • Electromyography (EMG) typically shows myopathic features, according to the American Association of Neuromuscular and Electrodiagnostic Medicine 6
  • Genetic testing is essential for definitive diagnosis, as noted by the American College of Medical Genetics 6, 5

Management

Cardiac Management

  • The American College of Cardiology recommends regular cardiac evaluation with echocardiography and ECG, at least annually for all LGMD subtypes with known cardiac involvement 1, 5
  • Early initiation of standard heart failure therapies is recommended when cardiac dysfunction is detected, according to the American Heart Association 5

Respiratory Management

  • The American Thoracic Society recommends regular assessment of respiratory function and evaluation for sleep-disordered breathing when clinically indicated 4, 5
  • Implementation of non-invasive ventilation is recommended when needed, as noted by the American Thoracic Society 4
  • Aggressive management of respiratory infections is crucial, according to the American Thoracic Society 4

Musculoskeletal Management

  • The American Academy of Physical Medicine and Rehabilitation recommends regular assessment of muscle strength, range of motion, and function 5, 7
  • Physical therapy is recommended to maintain mobility and prevent contractures, according to the American Physical Therapy Association 7
  • Orthotic devices and mobility aids are recommended as needed, as noted by the American Academy of Orthopaedic Surgeons 7

Prognosis

  • The American Academy of Neurology notes that prognosis varies widely depending on the specific genetic subtype, with cardiac and respiratory complications being major determinants of morbidity and mortality 1, 4

Evidence‑Based Diagnostic and Functional Assessment in Limb Girdle Muscular Dystrophy

Electromyography (EMG)

  • EMG demonstrates myopathic features—polyphasic motor unit potentials of short duration and low amplitude, with increased insertional activity, fibrillation potentials, sharp waves, or repetitive discharges—supporting a primary muscle disorder and guiding biopsy site selection. 8

Muscle Biopsy

  • Muscle biopsy remains a cornerstone for distinguishing inflammatory from non‑inflammatory myopathies and confirming LGMD, providing essential histopathologic confirmation. 8
  • Typical histopathology includes reduction or absence of dystrophin, presence of degenerating and regenerating fibers, and replacement of muscle by fat or connective tissue. [9][8]
  • Optimal biopsy technique: select a weak muscle identified by EMG abnormalities and obtain a specimen from the contralateral side to maximize diagnostic yield and reduce sampling error. 8

Differential Diagnosis

  • LGMD must be differentiated from other non‑inflammatory myopathies, including late‑onset muscular dystrophies such as dysferlinopathies, mitochondrial myopathies (characterized by subsarcolemmal and interfibrillar mitochondrial accumulation with “ragged red fibers”), drug‑induced myopathies (e.g., statins, corticosteroids), endocrine myopathies (thyroid or parathyroid disorders), and inflammatory myopathies (polymyositis, dermatomyositis) that show inflammatory infiltrates on biopsy. [9][8]

Strength and Range‑of‑Motion Assessment

  • Manual muscle testing (MRC scale) or quantitative myometry should be performed on muscles with strength grades 3–5 to objectively track disease progression. 10
  • Goniometric measurement of joint range of motion—focusing on hip, knee, ankle, elbow, wrist, and long‑finger flexors—helps identify early contractures and guide therapeutic interventions. 10

Functional Testing

  • In ambulatory patients, standardized timed tests (10‑meter walk, Gowers’ maneuver, stair climb, chair rise, 6‑minute walk) provide quantitative markers of functional ability. 10
  • In late‑ambulatory or non‑ambulatory patients, functional assessments include timed tasks for dressing, self‑care, writing, computer use, and wheelchair control to evaluate daily living capabilities. 10
  • Validated disease‑specific scales—Vignos lower‑extremity scale, North Star Ambulatory Assessment, Brooke upper‑extremity scale, and Motor Function Measure—offer reliable outcome measures for clinical monitoring and research trials. 10

Contracture Prevention and Exercise Prescription

  • Gentle stretching, use of standing devices, and selective surgical lengthening (e.g., iliotibial band) are recommended to prevent contracture formation while preserving joint mobility. 10
  • Low‑resistance exercise programs are advised to maintain functional strength; high‑resistance or eccentric training should be avoided as they may accelerate muscle damage. 10

REFERENCES

5

Diagnostic and Management Approaches for Fukutin-Related Muscular Dystrophies [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025